News

News


18 Apr 2011
Lienhardt C, Cook SV, Burgos M, Yorke-Edwards V, Rigouts L, Anyo G, Kim SJ, Jindani A, Enarson DA, Nunn AJ; Study C Trial Group. Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled...
13 Apr 2011
If you are having trouble viewing, click here . CORE Group Online Presentation about New TB Diagnostic Technology, Xpert®MTB/RI How does it work? Where can it be used? How might it make a difference in the global effort to stop TB? Hosted online by the CORE Group Tuberculosis Working Group on March...
11 Apr 2011
Monedero I, Caminero JA. Evidence for promoting fixed-dose combination drugs in tuberculosis treatment and control: a review. Int J Tuberc Lung Dis. 2011 Apr;15(4):433-9. In this week’s article, Monedero and Caminero conduct a critical review of research on the use of fixed-dosed combinations (FDCs...
6 Apr 2011
Photo by John-Michael Maas Each day, thousands of people around the world are affected by tuberculosis whether directly or indirectly, and every 20 seconds one of these people die. TB hits all ages and all races with great devastation, but has become so ingrained in history that it has been assumed...
4 Apr 2011
Frigati LJ, Kranzer K, Cotton MF, Schaaf HS, Lombard CJ, Zar HJ. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting. Thorax. 2011 Apr 2. [Epub ahead of print] This week, the focus is on...
30 Mar 2011
Today was the opening of the 2-day Stop TB Partnership’s Coordinating Board (CB) meeting in Washington, D.C. which included welcoming remarks by Dr. Rajiv Shah (Administrator, USAID), Ms. Lois Quam (Executive Director, GHI), and Dr. Howard Koh (Assistant Secretary, U.S. Depart. of HHS). Having the...
28 Mar 2011
The New York Academy of Sciences will be hosting a symposium entitled “New Frontiers in Marine Drug Discovery” on May 20, 2011. This 1-day symposium will overview the current state of the art in Marine Biomedicine and its role in the context of the drug discovery process – from the perspectives of...
24 Mar 2011
The following is an e-mail circulated on the Stop TB Advocacy Network from a TB patient named Pervaiz Tufail, location unknown. It is a powerful message from the patient’s perspective. Subject: TODAY IS WORD TB DAY BUT WHERE AM I? I heard Akram died of TB today, last week Rizwan died and I am...
23 Mar 2011
Today on World TB Day, the International Scientific Exchange Foundation of China (ISEFC) , announced the signing of a Memorandum of Understanding with the Global Alliance for TB Drug Development (TB Alliance) to establish the Global Health R&D Center of China (GHRC). This innovative center will...
22 Mar 2011
The Médecins Sans Frontières and The Union will release on World TB Day a new report entitled “DR-TB drugs under the microscope” outlining drugs currently available to treat drug-resistant tuberculosis (DR-TB) including product information, sources of the drug, quality status, and price. The...
21 Mar 2011
Chen TC, Lu PL, Lin CY, Lin WR, Chen YH. Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis. Int J Infect Dis. 2011 Mar;15(3):e211-6. Epub 2010 Dec 30. Chen, et al., conducted a meta-analysis to ascertain the answer to two...
16 Mar 2011
Photo: David Rochkind On World TB Day March 24, there will be a Congressional Briefing on multi-drug resistant TB (MDR-TB) where David Rochkind, the award winning photographer and Pulitzer Center grantee, will present his reporting and photography on his exploration into the MDR-TB crisis in...
14 Mar 2011
Summary: Dr. Eric Nuermberger is Associate Professor of Medicine in the Division of Infectious Diseases, Department of Medicine, at Johns Hopkins University School of Medicine. The WGND had the opportunity to talk with Dr. Nuermberger on a recent article entitled “PA-824 exhibits time-dependent...
9 Mar 2011
Global Health Primer by Disease This week BIO Ventures for Global Health launched a new online tool called the “Global Health Primer” which aims to be a clearinghouse of information geared to the biotech industry to encourage investments in neglected disease product development. The Primer...
7 Mar 2011
[wpaudio url=”/blog/media/podcasts/Andersen_Peter_finished.mp3″ text=”Click here to play the Peter Anderson Podcast” dl=”0″] Summary: Dr. Peter Andersen is Vice President of Vaccine Research and Development at Statens Serum Institut (SSI). The WGND had the opportunity to talk with Dr. Andersen on a...

Pages